期刊
KIDNEY INTERNATIONAL
卷 96, 期 5, 页码 1083-1099出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.kint.2019.05.026
关键词
epidemiology; inflammation; metabolic reprogramming; microvascular dysfunction; prevention; sepsis-associated acute kidney injury; sepsis-induced acute kidney injury; treatment
资金
- National Institutes of Health [UG3DK114861, UL1TR001857, K08GM117310]
Sepsis-associated acute kidney injury (S-AKI) is a frequent complication of the critically ill patient and is associated with unacceptable morbidity and mortality. Prevention of S-AKI is difficult because by the time patients seek medical attention, most have already developed acute kidney injury. Thus, early recognition is crucial to provide supportive treatment and limit further insults. Current diagnostic criteria for acute kidney injury has limited early detection; however, novel biomarkers of kidney stress and damage have been recently validated for risk prediction and early diagnosis of acute kidney injury in the setting of sepsis. Recent evidence shows that microvascular dysfunction, inflammation, and metabolic reprogramming are 3 fundamental mechanisms that may play a role in the development of S-AKI. However, more mechanistic studies are needed to better understand the convoluted pathophysiology of S-AKI and to translate these findings into potential treatment strategies and add to the promising pharmacologic approaches being developed and tested in clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据